Inventor · disambiguated record
Rekha Bansal
Also filed as: BANSAL REKHA · BANSAL REKHA P
24 granted patents·18 pending applications·94 citations·filing 1994–2024
94Inventor score
Top patents by PatentIndex Score
42 records- 0189US8664362B2Humanized and chimeric anti-properdin antibodiesBANSAL REKHA·Filed 2011·Granted Mar 4, 2014·9 cites·8 claims
- 0287US9243070B2Humanized and chimeric anti-factor Bb antibodies and uses thereofNOVELMED THERAPEUTICS INC·Filed 2013·Granted Jan 26, 2016·10 cites·17 claims
- 0386US8981060B2Method of inhibiting complement activation with factor Bb specific antibodiesBANSAL REKHA·Filed 2008·Granted Mar 17, 2015·9 cites·28 claims
- 0486US8192742B2Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereofBANSAL REKHA·Filed 2007·Granted Jun 5, 2012·6 cites·8 claims
- 0585US8435512B2Anti-properdin antibodiesBANSAL REKHA·Filed 2008·Granted May 7, 2013·8 cites·22 claims
- 0683US9676842B2Anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2014·Granted Jun 13, 2017·2 cites·4 claims
- 0783US5438150AProcess for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivativesSYNTEX INC·Filed 1994·Granted Aug 1, 1995·23 cites·19 claims
- 0882US9988441B2Methods of treating hemolytic disorders comprising administering anti-Bb antibodiesNOVELMED THERAPEUTICS INC·Filed 2015·Granted Jun 5, 2018·3 cites·13 claims
- 0981US9745367B2Alternative pathway specific antibodies for treating arthritisBANSAL REKHA·Filed 2012·Granted Aug 29, 2017·5 cites·2 claims
- 1081US9243060B2Humanized anti-factor C3b antibodies and uses thereofNOVELMED THERAPEUTICS INC·Filed 2013·Granted Jan 26, 2016·5 cites·15 claims
- 1180US10131706B2Anti-factor Bb antibodiesNOVELMED THERAPEUTICS INC·Filed 2015·Granted Nov 20, 2018·2 cites·12 claims
- 1280US9023831B2Methods and compositions of inhibiting complement and cellular activation with Dextran SulfateBANSAL REKHA·Filed 2008·Granted May 5, 2015·1 cites·4 claims
- 1380US7959919B2Method of inhibiting factor B-mediated complement activationNOVELMED THERAPEUTICS INC·Filed 2003·Granted Jun 14, 2011·6 cites·17 claims
- 1479US10696740B2Methods of treating ocular diseasesNOVELMED THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·1 cites·17 claims
- 1576US10858420B2Methods of treating hemolytic disorders comprising administering an anti-C3b antibodyNOVELMED THERAPEUTICS INC·Filed 2018·Granted Dec 8, 2020·1 cites·13 claims
- 1676US2025042981A1Monospecific and bispecific antibodies and antigen binding fragments thereofNOVELMED THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1775US10183989B2Methods of treating ocular diseasesNOVELMED THERAPEUTICS INC·Filed 2014·Granted Jan 22, 2019·1 cites·20 claims
- 1872US10711056B2Aglycosylated anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2012·Granted Jul 14, 2020·1 cites·7 claims
- 1971US9926366B2Methods of treating a hemolytic disorder comprising administering anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2013·Granted Mar 27, 2018·1 cites·16 claims
- 2067US11981727B2Monospecific and bispecific antibodies and antigen binding fragments thereofNOVELMED THERAPEUTICS INC·Filed 2021·Granted May 14, 2024·0 cites·8 claims
- 2163US9566297B2Methods and compositions for inhibiting cellular proliferation and surgical adhesionNOVELMED THERAPEUTICS INC·Filed 2014·Granted Feb 14, 2017·0 cites·14 claims
- 2263US2011160636A1Device and method for inhibiting complement activationBANSAL REKHA·Filed 2009·Application pending·0 cites
- 2363US2010015139A1METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Ba SPECIFIC ANTIBODIES AND USE THEREOFBANSAL REKHA·Filed 2009·Application pending·0 cites
- 2463US2010111946A1Inhibiting activation with human anti-factor c3 antibodies and use thereofBANSAL REKHA·Filed 2008·Application pending·0 cites
- 2563US2011262456A1Method of treating ischemia reperfusion injuryBANSAL REKHA·Filed 2009·Application pending·0 cites
- 2661US9040507B2Method for treating inflammatory conditionsBANSAL REKHA·Filed 2009·Granted May 26, 2015·0 cites·11 claims
- 2760US8940490B2Neoantibodies for diagnosing tissue injuryBANSAL REKHA·Filed 2011·Granted Jan 27, 2015·0 cites·18 claims
- 2859US2014127204A1Anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2957US9816999B2Neo antibodies for diagnostic imaging of tissue injuryNOVELMED THERAPEUTICS INC·Filed 2015·Granted Nov 14, 2017·0 cites·18 claims
- 3056US2012288493A1Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereofBANSAL REKHA·Filed 2012·Application pending·0 cites
- 3155US2010322921A1METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR Va ANTIBODIES AND USE THEREOFBANSAL REKHA·Filed 2007·Application pending·0 cites
- 3252US2016244513A1Method of inhibiting complement activation with human anti-factor c3 antibodies and uses thereofNOVELMED THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3350US2011311532A1Inhibition of complement and cellular activationBANSAL REKHA·Filed 2008·Application pending·0 cites
- 3450US2011195974A1Methods of treating inflammatory conditions with adrenergic antagonistsBANSAL REKHA·Filed 2008·Application pending·0 cites
- 3547US2014186348A1Humanized and chimeric anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3647US2013071396A1Method of inhibiting coagulation activation with human anti-factor v antibodies and use thereofBANSAL REKHA·Filed 2012·Application pending·0 cites
- 3746US8680075B2Methods and compositions for inhibiting cellular proliferation and surgical adhesionBANSAL REKHA·Filed 2010·Granted Mar 25, 2014·0 cites·11 claims
- 3842US2016207987A1Alternative pathway specific antibodies for treating arthritisNOVELMED THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3942US2018000932A1Formulation of aglycosylated therapeutic antibodiesNOVELMED THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4041US2015216876A1Method for treating inflammatory conditionsNOVELMED THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4139US2018002408A9AGLYCOSYLATED ANTI-Bb ANTIBODIES AND USES THEREOFNOVELMED THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4239US2019202898A9AGLYCOSYLATED ANTI-C3b ANTIBODIES AND USES THEREOFNOVELMED THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rekha Bansal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →